Prognostic Impact of FLT3-ITD Microclones in AML
Identifying tiny FLT3-ITD mutations could help doctors better predict which AML patients need more aggressive treatment despite current risk classifications.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Baseline Spleen Volume is Independently Associated With Survival…
Measuring spleen size on imaging may help identify CAR-T therapy candidates most likely to survive, improving how doctors select patients for this intensive treatment.
Early cancer detection or preventionFlagging urgent suspicion of lung cancer with AI CXR algorithms
AI can spot suspicious lung patterns on routine chest X-rays with better accuracy, potentially catching early cancers when treatment is more effective.
Near-term implementable findingIntraoperative artificial intelligence for brain tumor surgery
Surgeons can now learn tumor type and molecular features in real-time during brain surgery instead of waiting days, enabling better immediate surgical decisions.
Near-term implementable findingSevere Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes
Updated evidence clarifies how SGLT2 and DPP-4 inhibitors compare for infection risk, helping doctors choose safer diabetes medications for individual patients.